|
41 |
St.-Gallen-Konferenz 2011 zum primären Mammakarzinom Enthalten in Senologie Bd. 8, 2011, Nr. 02: 106-115
|
|
|
42 |
Zertifizierte multidisziplinäre Brustzentren: Ein Implementierungsprojekt der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Senologie in Partnerschaft mit der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe Enthalten in Senologie Bd. 8, 2011, Nr. 02: 92-95
|
|
|
43 |
A combination of transcriptome and methylation analyses reveals embryologically-relevant candidate genes in MRKH patients Enthalten in Orphanet journal of rare diseases Bd. 6, 28.5.2011, Nr. 1, date:12.2011: 1-12
|
|
|
44 |
Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay Enthalten in BMC cancer Bd. 12, 23.7.2012, Nr. 1, date:12.2012: 1-6
|
|
|
45 |
Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003–2007) from Germany as a proof of concept Enthalten in BMC cancer Bd. 8, 02.12.2008, Nr. 1, date:12.2008: 1-13
|
|
|
46 |
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1 Enthalten in Breast cancer research Bd. 10, 15.10.2008, Nr. 5, date:10.2008: 1-16
|
|
|
47 |
Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care Enthalten in BMC cancer Bd. 9, 14.7.2009, Nr. 1, date:12.2009: 1-13
|
|
|
48 |
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients Enthalten in BMC cancer Bd. 16, 25.7.2016, Nr. 1, date:12.2016: 1-8
|
|
|
49 |
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study Enthalten in Geburtshilfe und Frauenheilkunde Bd. 84, 2024, Nr. 02: e10-e10
|
|
|
50 |
Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine Enthalten in Geburtshilfe und Frauenheilkunde Bd. 80, 2020, Nr. 11: e289-e289
|
|